While the importance of chemical modifications of DNA and proteins is well established, relatively little is known about how the post-transcriptional modification of mRNA transcripts affects their function. The most common modified base seen on cellular mRNAs in mammals is N6-methyladenosine (m6A), and recent data demonstrate that the total loss of m6A formation can have severe deleterious consequences, for example blocking the differentiation of pluripotent stem cells. However, how m6A regulates mRNA expression remains to be established. Moreover, previous work has revealed that several viruses encode mRNAs that undergo m6A modification suggesting that such modifications likely exert a positive effect on virus replication. This grant proposal seeks to define the sites of m6A modification on HIV-1 transcripts and to determine how these modifications affect HIV-1 gene expression and replication. Using the PAR-CLIP technique, we have identified several specific binding sites for the human YTHDF m6A reader proteins on the HIV-1 genome that are also bound in vitro by an m6A-specific antibody. Of interest, these m6A editing sites are conserved across a wide range of HIV-1 isolates. We have demonstrated that these viral m6A sites are maintained in indicator constructs containing segments of the HIV-1 genome and have observed that mutagenesis of these m6A sites results in a significant reduction in mRNA expression. Consistent with the hypothesis that m6A editing positively regulates HIV-1 gene expression, we have observed that overexpression of the human YTHDF2 reader protein in human CD4+ T cells enhances HIV-1 replication while knock out of the YTHDF2 gene by genome editing inhibits HIV-1 replication. This grant first aims to define the locations of m6A modifications on the HIV-1 genome at single nucleotide resolution and to then quantify the degree of editing at each site. We will then use targeted viral mutagenesis to determine precisely how specific m6A modifications affect HIV-1 gene expression and replication. In parallel, we will examine how the overexpression, in CD4+ T cells, of key cellular proteins involved in ?writing?, ?reading? and ?erasing? m6A marks, or their elimination by genome editing using CRISPR/Cas, affects HIV-1 replication. Finally, we intend to extend this analysis to the experimentally tractable animal retrovirus murine leukemia virus in order to determine whether m6A editing represents a general strategy to promote retroviral gene expression and replication.

Public Health Relevance

HIV-1 produces messenger RNAs (mRNAs) that encode all the viral proteins. We have shown that these mRNAs are post-transcriptionally modified by addition of a methyl group at the N6 position of several specific adenosine residues (m6A). Moreover, we have also observed that m6A enhances viral gene expression. Here, we propose to determine exactly how m6A affects HIV-1 gene expression and whether inhibition of m6A addition can reduce HIV-1 replication.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI124973-01A1
Application #
9511953
Study Section
AIDS Molecular and Cellular Biology Study Section (AMCB)
Program Officer
Kuo, Lillian S
Project Start
2017-07-05
Project End
2018-06-30
Budget Start
2017-07-05
Budget End
2018-06-30
Support Year
1
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Duke University
Department
Genetics
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705